Font Size

SCREEN

Profile

Direction

Menu Style

isirv Optionx IX 2016


SAVE THE DATE 15 - 17 April 2015 

3rd International Symposium on Neglected Influenza Viruses

The Georgia Center at the University of Georgia, Athens, GA USA

This 3rd International Symposium on Neglected Influenza Viruses will retain the format and build on the success of the first two meetings held in Florida (2010) and Dublin (2013). This conference will explore the latest surveillance data, vaccination and control strategies, diagnostic techniques, experimental research data and epidemiological and economic impact studies relating to swine, canine and other non-human/non-avian influenza viruses.

For more information, click here 

SAVE THE DATE 2 - 4 June 2015 

4th ISIRV-AVG Conference 

The University of Texas at Austin, Texas USA

Novel Antiviral Therapies for Influenza and Other Respiratory Viruses : Bench to Bedside

This conference will focus on the pre-clinical and clinical development of therapeutics for influenza and other respiratory viruses, including RSV, SARS, MERS-CoV.


SAVE THE DATE 2 - 4 September 2015

1st International Meeting on Respiratory Pathogens

Furama Riverfront, Singapore

This ISIRV conference aims to be the world's premier respiratory pathogens (viruses, bacteria and others) meeting, covering a range of topics from emerging diseases, epidemiology, immunology, diagnostics, vaccines and therapeutics, and clinical management.


Members' Resources

The conference entitled 'Influenza and Other Respiratory Virus Infections: Advances in Clinical Management'  took place in Tokyo, Japan, on 4-6 June 2014. Resources from the meeting are currently available to isirv members in the members' area.

 
A summary report of  the isirv AVG discussion meeting on 'clinical trial endpoints for studies of antivirals in hospitalised and at risk influenza patients' is now available here.

Dr Lance Jennings has been appointed as the isirv Chair, taking over from Dr John Watson who stood down at the isirv AGM.  Full details of the isirv board members, including brief biographies, can be found in the 'about isirv' pages of the website.

Resources from the recent Options VIII conference in Cape Town, including web-casts of the plenary presentations, are available in the members area of the isirv website.
 

 

MERS-CoV: information and links to other sources of information on this evolving situation is available through the news section. 

Influenza A(H7N9) in China: information and links to other sources of information is available through the news section. 


The isirv journal, Influenza and other Respiratory Viruses is now published in an Online Only format. No printed issue will be produced but authors will still be able to order offprints of their own articles. Further information is available here

International Society for Influenza and other Respiratory Virus Diseases: isirv

isirv is an independent and international scientific professional society promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. It aims to provide opportunities for the exchange of information and for international collaboration between those with a scientific interest in any aspect of influenza and other respiratory viral infections. Thus, its activities include the organisation of scientific meetings, promotion of scientific and clinical training, dissemination of information on the impact of acute respiratory viral disease both locally and globally, and publication of scientific information, notably through the journal Influenza and other Respiratory Diseases. The society has lead responsibility for organizing the Options for the Control of Influenza conferences, the largest international gatherings exclusively devoted to influenza prevention, control and treatment, including seasonal flu and pandemic preparedness. Read More

isirv Antiviral Group (isirv-AVG)

The isirv Antiviral Group (isirv-AVG) was established as a special interest group of isirv at the time of merger in April 2011 of the former Neuraminidase Inhibitor Susceptibility Network (NISN) with isirv.

Its specific objectives are to promote understanding of the clinical use of antivirals against respiratory viruses, collate and provide up to date information on the emergence of antiviral resistance, and communicate expert commentary on preclinical and clinical development of potential novel/new antivirals in this area. Read More